Terms: = Prostate cancer AND WWTR1, ENSG00000018408, 25937, Q9GZV5, DKFZP586I1419
4 results:
1. AR activates YAP/TAZ differentially in prostate cancer.
Salem O; Jia S; Qian BZ; Hansen CG
Life Sci Alliance; 2023 Sep; 6(9):. PubMed ID: 37385752
[TBL] [Abstract] [Full Text] [Related]
2. Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity.
Pearson JD; Huang K; Pacal M; McCurdy SR; Lu S; Aubry A; Yu T; Wadosky KM; Zhang L; Wang T; Gregorieff A; Ahmad M; Dimaras H; Langille E; Cole SPC; Monnier PP; Lok BH; Tsao MS; Akeno N; Schramek D; Wikenheiser-Brokamp KA; Knudsen ES; Witkiewicz AK; Wrana JL; Goodrich DW; Bremner R
Cancer Cell; 2021 Aug; 39(8):1115-1134.e12. PubMed ID: 34270926
[TBL] [Abstract] [Full Text] [Related]
3. TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells.
Lin M; Bu C; He Q; Gu J; Wang H; Feng N; Jiang SW
Oncol Rep; 2020 Aug; 44(2):747-756. PubMed ID: 32468018
[TBL] [Abstract] [Full Text] [Related]
4. SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression.
Esposito S; Russo MV; Airoldi I; Tupone MG; Sorrentino C; Barbarito G; Di Meo S; Di Carlo E
Oncotarget; 2015 Jul; 6(19):17121-34. PubMed ID: 25686823
[TBL] [Abstract] [Full Text] [Related]
